文档介绍：Advances in Clinical Medicine 临床医学进展, 2019, 9(5), 697-702
Published Online May 2019 in Hans.
/
Progress in the Diagnosis and Treatment
of Prostate Cancer Specific Membrane
Antigen for Prostate Cancer
Hongjun Shen
Urology Department of Chongqing Yubei District People’s Hospital, Chongqing
Received: May 3rd, 2019; accepted: May 21st, 2019; published: May 28th, 2019
Abstract
Prostate specific membrane (PSMA) is a type 2 integral membrane glycoprotein with folate hy-
drolase and carboxypeptidase, which has high prostate tissue specificity and is high in poorly dif-
ferentiated and metastatic prostate cancer. The expression is positively correlated with the de-
gree of malignancy of prostate tumors. Based on this, the imaging method for detecting and treat-
ing prostate cancer with PSMA is continuously developed. The aim of this article is to review the
progress of PSMA as a marker for imaging diagnosis and treatment of prostate cancer.